Literature DB >> 15298356

Who are more insulin resistant, people with IFG or people with IGT?

T Wasada, H Kuroki, K Katsumori, H Arii, A Sato, K Aoki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15298356     DOI： 10.1007/s00125-004-1339-1

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  21 in total

1.  Inhibition of Renal Sodium-Glucose Cotransport With Empagliflozin Lowers Fasting Plasma Glucose and Improves β-Cell Function in Subjects With Impaired Fasting Glucose.

Authors:  Muhammad Abdul-Ghani; Hussein Al Jobori; Giuseppe Daniele; John Adams; Eugenio Cersosimo; Curtis Triplitt; Ralph A DeFronzo
Journal:  Diabetes       Date:  2017-06-13       Impact factor: 9.461

Review 2.  Impaired fasting glucose as a treatment target in diabetes management.

Authors:  Rene A Oliveros; Adrienne S Zion; Yelena Rosenberg; Carrie Lynn Selvaraj; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

3.  Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range.

Authors:  Diedre Winner; Luke Norton; Mustafa Kanat; Ruth Arya; Marcel Fourcaudot; Andrea Hansis-Diarte; Devjit Tripathy; Ralph A DeFronzo; Christopher P Jenkinson; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2014-05-05       Impact factor: 5.958

4.  Minimal contribution of fasting hyperglycemia to the incidence of type 2 diabetes in subjects with normal 2-h plasma glucose.

Authors:  Muhammad A Abdul-Ghani; Michael P Stern; Valeriya Lyssenko; Tiinamaija Tuomi; Leif Groop; Ralph A Defronzo
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 17.152

Review 5.  Pathophysiology of prediabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

6.  The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.

Authors:  Muhammad A Abdul-Ghani; Masafumi Matsuda; Rucha Jani; Christopher P Jenkinson; Dawn K Coletta; Kohei Kaku; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

7.  Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.

Authors:  K Faerch; A Vaag; J J Holst; C Glümer; O Pedersen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

8.  Immunoglobulin E and mast cell proteases are potential risk factors of impaired fasting glucose and impaired glucose tolerance in humans.

Authors:  Zhen Wang; Hong Zhang; Xu-Hui Shen; Kui-Li Jin; Guo-Fen Ye; Wei Qiu; Li Qian; Bo Li; Yong-Hong Zhang; Guo-Ping Shi
Journal:  Ann Med       Date:  2012-10-30       Impact factor: 4.709

9.  Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.

Authors:  Mariam Alatrach; Christina Agyin; Rucha Mehta; John Adams; Ralph A DeFronzo; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2019-01-01       Impact factor: 5.958

Review 10.  Plasma glucose concentration and prediction of future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.